BEAT.NASDAQHeartbeam, INC

Form 4: HeartBeam President Robert Eno Purchases Shares

Sentiment:

Statement of Changes in Beneficial Ownership


HeartBeam President Robert Paul Eno acquired 12,500 shares of common stock at $0.80 per share in a public offering.

Capital raiseThe filing confirms the completion of an underwritten public offering of 12,500,000 shares of common stock which closed on April 16, 2026.

Summary

  • Robert Paul Eno, President of HeartBeam, Inc., purchased 12,500 shares of common stock.
  • The transaction occurred on April 16, 2026, at a price of $0.80 per share.
  • The purchase was made in connection with the company's underwritten public offering.
  • Following this transaction, the reporting person holds a total of 36,742 shares, which includes 23,333 vested RSUs.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as executive participation in a public offering indicates alignment and confidence in the company's future.

Positives

  • Insider confidence is demonstrated by the President's participation in the company's public offering.
  • The purchase aligns the interests of the President with those of the shareholders.

Negatives

  • NA

Risks

  • Investment in equity securities involves market volatility and the risk of loss of capital.

Future Outlook

The filing does not provide forward-looking guidance beyond the context of the completed public offering.

Management Comments

  • NA

Industry Context

StockSavvy.ai notes that insider participation in public offerings is generally viewed as a positive signal of management's belief in the company's long-term strategic direction and valuation.

Comparison to Industry Standards

  • Insider participation in capital raises is a standard practice in the biotech and medical device sectors to signal confidence to institutional investors.

Legal Proceedings

  • NA

Related Party Transactions

  • NA

Stakeholder Impact

  • Shareholders may view the insider purchase as a vote of confidence in the company's recent capital raise.

Next Steps

  • Ongoing monitoring of insider activity and future SEC filings regarding company performance.

Key Dates

DateDescription
2025-10-02Date of previous Form 4 filing regarding RSU vesting.
2026-04-14Pricing date of the underwritten public offering.
2026-04-16Transaction date and closing date of the public offering.

Keywords

HeartBeam, BEAT, Insider Trading, Form 4, Equity Purchase, Public Offering

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.